Scharnagl, H; Stojakovic, T; Winkler, K; Marz, W; Boehm, B.
HMG-COA reductase inhibitor cerivastatin lowers advanced glycosylation end-products in patients with type 2 diabetes
ATHEROSCLER SUPPL 2005 6: 78-78.
Doi: 10.1016/S1567-5688(05)80311-3
Web of Science
FullText
FullText_MUG